Charles Schwab
OSIR

Charles Schwab’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Charles Schwab’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-58,865
Closed -$290K – 3108
2016
Q4 		$290K Buy
58,865
+2,926
+5% +$15K ﹤0.01% 2860
2016
Q3 		$278K Buy
55,939
+2,458
+5% +$12.6K ﹤0.01% 2814
2016
Q2 		$273K Buy
53,481
+756
+1% +$4.07K ﹤0.01% 2819
2016
Q1 		$302K Buy
52,725
+918
+2% +$6.41K ﹤0.01% 2774
2015
Q4 		$538K Sell
51,807
-130,602
-72% -$1.77M ﹤0.01% 2615
2015
Q3 		$3.37M Sell
182,409
-4,424
-2% -$85.4K 0.01% 1743
2015
Q2 		$3.64M Buy
186,833
+146,301
+361% +$2.59M 0.01% 1757
2015
Q1 		$713K Sell
40,532
-5,230
-11% -$87.9K ﹤0.01% 2512
2014
Q4 		$732K Buy
45,762
+1,220
+3% +$16.3K ﹤0.01% 2475
2014
Q3 		$561K Buy
44,542
+964
+2% +$13.8K ﹤0.01% 2547
2014
Q2 		$681K Buy
43,578
+6,196
+17% +$91.1K ﹤0.01% 2504
2014
Q1 		$491K Buy
37,382
+1,140
+3% +$17.8K ﹤0.01% 2594
2013
Q4 		$583K Buy
36,242
+1,368
+4% +$21.8K ﹤0.01% 2540
2013
Q3 		$584K Buy
34,874
+1,843
+6% +$27.3K ﹤0.01% 2485
2013
Q2 		$334K Buy
+33,031
New +$347K ﹤0.01% 2692

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Charles Schwab's OSIR Position: Q1 2017 in Review

Charles Schwab sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 58,865 shares — an estimated $290K sold.

Charles Schwab first reported a position in OSIR in Q2 2013 and held it in 15 quarters. The position peaked at $3.64M in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Charles Schwab reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Charles Schwab sold 58,865 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $290K.
  • Charles Schwab first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
  • Charles Schwab's Osiris Therapeutics, Inc. Common Stock position peaked at $3.64M in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.